Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP272554.RARJuzG_FJaSAs1PP5pfWT5vqEHyRgPk2dld_FMBcYaJQ130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP272554.RARJuzG_FJaSAs1PP5pfWT5vqEHyRgPk2dld_FMBcYaJQ130_assertion type Assertion NP272554.RARJuzG_FJaSAs1PP5pfWT5vqEHyRgPk2dld_FMBcYaJQ130_head.
- NP272554.RARJuzG_FJaSAs1PP5pfWT5vqEHyRgPk2dld_FMBcYaJQ130_assertion wasGeneratedBy ECO_0000203 NP272554.RARJuzG_FJaSAs1PP5pfWT5vqEHyRgPk2dld_FMBcYaJQ130_provenance.
- NP272554.RARJuzG_FJaSAs1PP5pfWT5vqEHyRgPk2dld_FMBcYaJQ130_assertion wasDerivedFrom befree-20140225 NP272554.RARJuzG_FJaSAs1PP5pfWT5vqEHyRgPk2dld_FMBcYaJQ130_provenance.
- NP272554.RARJuzG_FJaSAs1PP5pfWT5vqEHyRgPk2dld_FMBcYaJQ130_assertion SIO_000772 17295209 NP272554.RARJuzG_FJaSAs1PP5pfWT5vqEHyRgPk2dld_FMBcYaJQ130_provenance.
- NP272554.RARJuzG_FJaSAs1PP5pfWT5vqEHyRgPk2dld_FMBcYaJQ130_assertion evidence source_evidence_literature NP272554.RARJuzG_FJaSAs1PP5pfWT5vqEHyRgPk2dld_FMBcYaJQ130_provenance.
- NP272554.RARJuzG_FJaSAs1PP5pfWT5vqEHyRgPk2dld_FMBcYaJQ130_assertion description "[Prior inactivation of PARP protected both cell lines from the initial decrease in NAD+ and improved the survival of LNCaP cells following combined EGF and IR treatment.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP272554.RARJuzG_FJaSAs1PP5pfWT5vqEHyRgPk2dld_FMBcYaJQ130_provenance.